191 related articles for article (PubMed ID: 17962436)
81. Prevalence of BRAF and NRAS mutations in fast-growing melanomas.
Nagore E; Hacker E; Martorell-Calatayud A; Traves V; Guillen C; Hayward NK; Whiteman D
Pigment Cell Melanoma Res; 2013 May; 26(3):429-31. PubMed ID: 23448684
[No Abstract] [Full Text] [Related]
82. Primary pulmonary melanoma: a report of two cases.
Watanabe M; Yamamoto H; Hashida S; Soh J; Sugimoto S; Toyooka S; Miyoshi S
World J Surg Oncol; 2015 Sep; 13():274. PubMed ID: 26376781
[TBL] [Abstract][Full Text] [Related]
83. A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases.
Zalaudek I; Ciarrocchi A; Piana S; Argenziano G; Torricelli F; Sancisi V; Gandolfi G; Longo C; Moscarella E; Banzi C; Nicoli D
J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):387-390. PubMed ID: 24393566
[TBL] [Abstract][Full Text] [Related]
84. Mutational analysis of the BRAF gene in transitional cell carcinoma of the bladder.
Boulalas I; Zaravinos A; Delakas D; Spandidos DA
Int J Biol Markers; 2009; 24(1):17-21. PubMed ID: 19404918
[TBL] [Abstract][Full Text] [Related]
85. Universal BRAF State Detection by the Pyrosequencing®-Based U-BRAF(V⁶⁰⁰) Assay.
Skorokhod A
Methods Mol Biol; 2015; 1315():63-82. PubMed ID: 26103892
[TBL] [Abstract][Full Text] [Related]
86. Protein expression of KIT, BRAF, GNA11, GNAQ and RASSF1 in feline diffuse iris melanomas.
Rushton JG; Korb M; Kummer S; Reichart U; Fuchs-Baumgartinger A; Tichy A; Nell B
Vet J; 2019 Jul; 249():33-40. PubMed ID: 31239162
[TBL] [Abstract][Full Text] [Related]
87. Comparative Methods to Improve the Detection of BRAF V600 Mutations in Highly Pigmented Melanoma Specimens.
Frouin E; Maudelonde T; Senal R; Larrieux M; Costes V; Godreuil S; Vendrell JA; Solassol J
PLoS One; 2016; 11(7):e0158698. PubMed ID: 27466810
[TBL] [Abstract][Full Text] [Related]
88. Mutation analysis of metastatic melanomas in the central nervous system: results of a panel of 5 genes in 48 cases.
Gamsizkan M; Yilmaz I; Simsek HA; Onguru O; Griffin A; Tihan T
Clin Neuropathol; 2016; 35(4):178-85. PubMed ID: 27117140
[TBL] [Abstract][Full Text] [Related]
89. Malignant melanoma arising from a perianal fistula and harbouring a BRAF gene mutation: a case report.
Martinez-Cadenas C; Bosch N; Peñas L; Flores-Couce E; Ochoa E; Munárriz J; Aracil JP; Tajahuerce M; Royo R; Lozoya R; Boldó E
BMC Cancer; 2011 Aug; 11():343. PubMed ID: 21827678
[TBL] [Abstract][Full Text] [Related]
90. Variables that influence BRAF mutation probability: A next-generation sequencing, non-interventional investigation of BRAFV600 mutation status in melanoma.
Gaiser MR; Skorokhod A; Gransheier D; Weide B; Koch W; Schif B; Enk A; Garbe C; Bauer J
PLoS One; 2017; 12(11):e0188602. PubMed ID: 29176861
[TBL] [Abstract][Full Text] [Related]
91. External quality assessment of BRAF molecular analysis in melanoma.
Deans ZC; Wallace A; O'Sullivan B; Purvis A; Camus S; Fairley JA; Gonzalez D
J Clin Pathol; 2014 Feb; 67(2):120-4. PubMed ID: 24098023
[TBL] [Abstract][Full Text] [Related]
92. Advances in drug development. BRAF validation in melanoma.
Flaherty K
Clin Adv Hematol Oncol; 2010 Jan; 8(1):31-4. PubMed ID: 20351680
[No Abstract] [Full Text] [Related]
93. Exclusion of BRAFV599E as a melanoma susceptibility mutation.
Meyer P; Klaes R; Schmitt C; Boettger MB; Garbe C
Int J Cancer; 2003 Aug; 106(1):78-80. PubMed ID: 12794760
[TBL] [Abstract][Full Text] [Related]
94. Iris melanoma.
Henderson E; Margo CE
Arch Pathol Lab Med; 2008 Feb; 132(2):268-72. PubMed ID: 18251588
[TBL] [Abstract][Full Text] [Related]
95. [New molecular pathological strategies for malignant iris tumors].
Kakkassery V; Jünemann AM; Scheef BO; Grisanti S; Heindl LM
Ophthalmologe; 2019 Apr; 116(4):324-331. PubMed ID: 30623224
[TBL] [Abstract][Full Text] [Related]
96. T1799A BRAF mutation is common in PUVA lentigines.
Lassacher A; Worda M; Kaddu S; Heitzer E; Legat F; Massone C; Cerroni L; Kerl H; Ananthaswamy HN; Wolf P
J Invest Dermatol; 2006 Aug; 126(8):1915-7. PubMed ID: 16557238
[No Abstract] [Full Text] [Related]
97. BRAF V599E mutation occurs in Spitz and Reed naevi.
La Porta CA; Cardano R; Facchetti F; Presicce P; Rao S; Privitera E; Clemente C; Mihm MC
J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1164-5. PubMed ID: 16987295
[No Abstract] [Full Text] [Related]
98. Molecular profiling of vitreous fluid by massively parallel sequencing: a case series.
Hirschhorn JW; Snider JS; Lindsey KG; Schandl CA
J Am Soc Cytopathol; 2020; 9(4):254-257. PubMed ID: 32423686
[TBL] [Abstract][Full Text] [Related]
99. Gene expressing profiling of iris melanomas.
Harbour JW; Wilson D; Finger PT; Worley LA; Onken MD
Ophthalmology; 2013 Jan; 120(1):213, 213.e1-3. PubMed ID: 23283188
[No Abstract] [Full Text] [Related]
100. Detection of mutated BRAFV600E variant in circulating DNA of stage III-IV melanoma patients.
Daniotti M; Vallacchi V; Rivoltini L; Patuzzo R; Santinami M; Arienti F; Cutolo G; Pierotti MA; Parmiani G; Rodolfo M
Int J Cancer; 2007 Jun; 120(11):2439-44. PubMed ID: 17315191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
